“adolor” Archives

Entry Author Date Location
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
Hadapt Gets Series A, Cisco Buys BNI, Cubist Acquisition of Adolor Valued at $415M, & More Boston-Area Deals News 10/26/11 Boston
Cubist Says Adolor Deal Offers “Free Option on Billion-Dollar Program” 10/26/11 Boston
Page 1 of 1